Assessment of Pentraxin Levels in the Gingival Fluid of Abutment Teeth in the Context of the Use of Fixed Dentures

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07271563

Enrollment

Registered

2025-12-09

Start date

2023-03-01

Completion date

2024-08-01

Last updated

2025-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Disease, Periodontal Diseases, Prosthodontics

Brief summary

The use of fixed dentures in prosthetic treatment requires a thorough analysis of clinical factors such as: the condition of the abutments subject to grinding procedures, the degree of their loosening, the extent of missing teeth, and the condition of the periodontal tissues. An important step in prosthetic treatment is planning subsequent procedures, including the grinding of the crowns of the natural teeth. Often, the initial stages of gingivitis are not visible during a clinical examination \[1-4\].

Interventions

DIAGNOSTIC_TESTDiagnostic Pentraxine test

Diagnostic test - in order to measure Pantraxine level in gingival fluid was performed.

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* appropriate age range of patients, indication for the use of fixed dentures, no signs of gingivitis in the clinical examination

Exclusion criteria

* any autoimmune disease or other systemic disease which could alter the course of periodontal disease, the desire to withdraw from participation in the research and the occurrence of general and local diseases

Design outcomes

Primary

Measure	Time frame
Concentration of pentraxine	March 2023- August 2024

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026